Close Menu

Proteome Sciences

Proteome Sciences appointed Martin Diggle to its board as a non-executive director. Diggle is a director and partner at Vulpes Investment Management, where he manages the Vulpes Life Sciences Fund, which holds roughly 16 percent of Proteome Sciences’ ordinary shares.

NEW YORK (GenomeWeb News) – Proteome Sciences today said that revenues for the first half of 2014 were down 12 percent year over year.

NEW YORK (GenomeWeb) – Proteome Sciences said this week that it has signed a $2 million contract with Genting TauRx Diagnostic Centre, an affiliate of TauRx Therapeutics, to provide protein biomarker work in support of the company's Phase III trial of its Alzheimer's drug LMTX.

NEW YORK (GenomeWeb) – Proteome Sciences said today that it has signed a $2 million contract with Genting TauRx Diagnostic Centre, an affiliate of TauRx Therapeutics, to provide protein biomarker work in support of the company's Phase III trial of its Alzheimer's drug LMTX.

NEW YORK (GenomeWeb) – A team led by researchers from King's College London and Proteome Sciences has identified a panel of 10 protein biomarkers that could help predict patients likely to progress from mild cognitive impairment to Alzheimer's disease.

Provista Diagnostics has appointed Rao Mulpuri as chief operating officer.
Mulpuri was previously vice president of laboratory operations for AssureRx Health, and has also held senior positions at Beckman Coulter Genomics and Cogenics.

Proteome Sciences this week posted 2013 revenues of £2.14 million ($3.59 million), up 86 percent from £1.15 million in 2012.

Proteome Sciences has published the first peer-reviewed study of its Sysquant phosphorylation assay, using the product to investigate signaling pathways in pancreatic cancer.

Perthera has hired Subha Madhavan, as its chief data officer. Madhavan will head up the planning and organization of Perthera's data analytic framework, standards, and quality control.

NEW YORK (GenomeWeb News) – Proteome Sciences today announced a conditional placement of nearly 17.9 million new ordinary shares in order to raise £5 million ($8.3 million).

Pages

A New Zealand minister says the country's genetic modification laws need to be re-examined to help combat climate change, the New Zealand Herald reports.

A new analysis finds some cancers receive more nonprofit dollars than others.

An Australian mother's conviction in the deaths of her children may be re-examined after finding that two of the children carried a cardiac arrhythmia-linked gene variant.

In Science this week: comparative analysis of sex differences in mammal gene expression, and more.